Overview
This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are:
- to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring blood glucose with a glucometer).
- to assess change in continuous glucose monitoring-derived glycemic outcomes among the pharmacist-led continuous glucose monitoring cohort (intervention group)
- to assess change in health behavior among the pharmacist-led continuous glucose monitoring cohort (intervention group)
Eligibility
Inclusion Criteria:
- type 2 diabetes
- hemoglobin A1c ≥ 8%
- compatible smartphone with FreeStyle Libre 2 continuous glucose monitoring system
- current use and access to a glucometer for self-monitoring of blood glucose
Exclusion Criteria:
- any continuous glucose monitor use within 6 months prior to study enrollment
- pregnant and planning to become pregnant during study time frame
- history of hypoglycemia requiring third party assistance
- history of diabetic ketoacidosis or hyperosmolar hyperglycemic state within 6 months prior to study enrollment
- known allergy to medical grade adhesives
- current use of systemic steroids for any medical condition
- current use of dialysis